The Venture Codex Logo

The Venture Codex

IBG Sachsen-Anhalt

Kantstraße 5, Magdeburg, Sachsen-Anhalt, 39104, Germany

Overview

IBG Beteiligungsgesellschaft Sachsen-Anhalt is a venture capital firm makes investments in territories such as Germany and Denmark.

Total investments
11
Lead investments
3
Investments · 12mo
2
Active investors
1

Sector focus

  • Financial Services
  • Venture Capital
Visit website

Investment portfolio

  • Be2Byte

    Led · Equity · Aug 2026

    Be2Byte builds LabThunder, a SaaS platform that centralizes device management, digital logbooks and operational knowledge for laboratories and integrates an AI assistant called Thunder AI to help staff find information, troubleshoot issues and reduce downtime. The platform targets analytical service labs, environmental and food analytics, and clinical and academic labs, with entry into the regulated pharmaceutical sector planned for late 2027. A cited deployment at the ISO-17025 accredited Zentrallabor Witowski reduced documentation work by over 70%, replaced 107 paper logbooks, and was rolled out in ten weeks. The founding team includes CEO and co-founder Julian Weber (16 years’ lab experience), co-founder and CRO Manuel Diaz, and CTO Robert Perez. The company is based in Magdeburg and recently raised €500,000 from the IBG-Fonds managed by bmp Ventures to fund expansion and product development.

  • Sedivention

    Led · Seed · May 2026

    Sedivention is developing a minimally invasive outpatient therapy that uses a specially designed balloon catheter to deliver targeted cryoablation to interrupt hunger-related signals in the vagus nerve. A functional prototype has been developed and tested, and the company aims to generate initial clinical data via a first-in-human study. With the €2.9M seed round, Sedivention plans to advance product development and prepare for regulatory and market-entry steps. The therapy is intended as a one-time procedure without implants or ongoing medication and aims to offer a scalable alternative to bariatric surgery and chronic drug therapies. In the long term, Sedivention seeks to replace highly invasive surgical procedures with outpatient interventional treatments to improve access to effective obesity care.

  • RAYDIAX

    Participated · Seed · Oct 2023

    Raydiax is a 2022 spin-off from the STIMULATE research campus at Otto von Guericke University Magdeburg that is building TACT, a therapy assistance CT scanner designed for use directly in operating rooms. The system offers real-time, focused CT imaging that supports planning, execution, and monitoring of interventional oncology procedures while aiming to cut radiation exposure, shorten procedure times, and enable new techniques such as robot-assisted surgery through a larger gantry opening. Having completed a pre-clinical prototype during its seed phase, the company is now preparing first-in-human studies and moving the device toward production readiness and regulatory approval. Raydiax will also scale its sales, manufacturing, and quality functions in advance of initial commercial installations. Management believes the technology fills a critical workflow gap in interventional radiology and could establish a new device category for minimally invasive cancer treatment. The firm is headquartered in Magdeburg’s Science Harbor and is led by CEO and co-founder Dr. Thomas Hoffmann. Current financial backing totals €7.5 million in Series A1 capital, supplemented by earlier seed funding (undisclosed).

  • intelligent fluids GmbH

    Participated · Series B · Mar 2023

    Intelligent fluids develops non-toxic, skin-friendly cleaning solutions for industrial and professional use. Led by CEO Christian Römlein, its cleaners serve sectors from oil and gas and LED displays to adhesive removal and microelectronics. The products are designed to combine cleaning efficiency with ecological safety for use in production, trade, crafts and households. The company raised €10m in a Series B financing to support operational growth. It plans to use the funds to grow the team and increase manufacturing capacity at its German plant, and to initiate global expansion by establishing manufacturing entities in the USA, India, MENA and Taiwan.

  • Solar Materials

    Participated · Equity · Mar 2023

    SOLAR MATERIALS has developed a patented process to recover high-quality, sort-pure materials — including glass, aluminum, copper, silver and silicon — from end-of-life crystalline silicon solar modules, which comprise more than 95% of the global installed base. The technology has been industrially validated and the company positions modules as a resource rather than waste, addressing rising volumes of retired panels in Europe. SOLAR MATERIALS is scaling its recycling technology across larger industrial sites and is working to extend the process to additional module technologies. The company has secured up to €20 million in a Series B to accelerate European scale-up and site buildout, and has formed a strategic partnership with NOVA by Saint-Gobain to feed recycled glass into float-glass production. No specific revenue, user or other operating metrics were disclosed in the article.

Team